Freeman G, Siefried KJ, Roberts DM, Rodgers C, Nic Ionmhain U, Ramanathan J, et al. Phenobarbital to manage severe gamma-hydroxybutyrate withdrawal: A case series. Drug Alcohol Rev 2022. https://www.ncbi.nlm.nih.gov/pubmed/36269081
Kamal RM, van Noorden MS, Wannet W, Beurmanjer H, Dijkstra BA, Schellekens A. Pharmacological Treatment in gamma-Hydroxybutyrate (GHB) and gamma-Butyrolactone (GBL) Dependence: Detoxification and Relapse Prevention. CNS Drugs 2017;31(1):51-64. https://www.ncbi.nlm.nih.gov/pubmed/28004314
Novel Psychoactive Treatment UK Network (NEPTUNE) Expert Group. Guidance on the Management of Acute and Chronic Harms of Club Drugs and Novel Psychoactive Substances. London: NEPTUNE; 2015. https://www.cnwl.nhs.uk/neptune
Phan V, Arunogiri S, Lubman DI. The assessment and management of gamma hydroxybutyrate use in general practice. Aust J Gen Pract 2020;49(1-2):73-8. https://www.ncbi.nlm.nih.gov/pubmed/32008260
The Australian and New Zealand Committee on Resuscitation (ANZCOR). ANZCOR Guideline 6 – Compressions. In: The ARC Guidelines. Melbourne: Australian Resucitation Council (ARC); 2021. https://resus.org.au/the-arc-guidelines/